U.S. Department of Health and Human Services
Hemodialysis Vascular Access Roundtable

Hemodialysis Vascular Access Roundtable

7/18/2016 12:00 AM
7/18/2016 12:00 AM
Yes
No

Program Content

Kevin C. Abbott, MD, MPH
Program Officer, KUH, NIDDK
T: 301-594-7714
E: kevin.abbott@nih.gov

Meeting Logistics

Melissa Frohna
The Scientific Consulting Group, Inc.
T: 301-670-4990
E: mfrohna@scgcorp.com

Bethesda
 
John Edward Porter Neuroscience Research Center

Event Details

Background

Vascular access is required for all patients with end-stage renal disease (ESRD) who undergo maintenance hemodialysis. Patients who start dialysis with a catheter accrue in excess of $40,000 more in annual costs, compared with patients who start dialysis with a fistula. Importantly, it has been well documented that catheter use for hemodialysis is associated with a higher risk of complications, including serious and life threatening infections, compared to other more permanent forms of access including fistulas or grafts. Although fistulas are the recommended type of vascular access in many patients currently the overwhelming majority of patients in the U.S. start hemodialysis with catheters, placing them at high and avoidable risk for adverse outcomes. Although fistulas are often the preferred type of vascular access, they often do not mature to be used for regular hemodialysis.

In September 2015 the NIDDK held a workshop on hemodialysis vascular access (Hemodialysis Vascular Access: Taking the Next Steps) to identify future directions in clinical and basic research. To continue the process of identifying clinically important research to improve hemodialysis vascular access in the U.S. hemodialysis patient population the Institute will hold a second meeting, A Roundtable on Clinical Research for Hemodialysis Vascular Access, in the summer of 2016. Selected participants of the roundtable will be asked to present their two most important (highest priority) clinical research studies to move the field forward. The proposed studies will be discussed in depth by all attendees, and at the end of the meeting a prioritized list will be established. Participants of this meeting will include clinical researchers, leaders of large dialysis organizations and representatives from the Centers for Medicare & Medicaid Services, the Patient Centered Outcomes Research Institute, Agency for Healthcare Research & Quality, Department of Veterans Affairs, the Food and Drug Administration, professional societies for kidney disease and advocacy groups for patients with chronic kidney disease, among others.

Registration Deadline

July 14, 2016​​​​​​​​​​

Agenda

July 18, 2015

   
7:30 a.m. – 8:00 a.m. Registration

 

   
8:00 a.m. – 8:10 a.m. Welcome from NIDDK
Robert Star
   
8:10 a.m. – 8:20 a.m. Overview of the roundtable
Michael Allon

Initial presentation of research proposals

   
8:20 a.m. – 8:30 a.m. Presentation 1: Leveraging healthcare provider organizations, large dialysis organization and vascular access centers to develop a pragmatic, precision medicine approach to dialysis vascular access care
Prabir Roy-Chaudhury
   
8:30 a.m. – 8:50 a.m. Discussion of presentation 1
   
8:50 a.m. – 9:00 a.m. Presentation 2: RCT of early vs late AVF surgery in pre-dialysis patients
Allen Nissensen
   
9:00 a.m. – 9:20 a.m. Discussion of presentation 2
   
9:20 a.m. – 9:30 a.m. Presentation 3: RCT of AVF vs AVG surgery in high risk patients starting HD with a CVC
Michael Allon
   
9:30 a.m. – 9:50 a.m. Discussion of presentation 3
   
9:50 a.m. – 10:10 a.m. Break
   
10:10 a.m. – 10:20 a.m. Presentation 4: Prospective evaluation of interventional strategies to salvaging non-maturing AVFs
Scott Berceli
   
10:20 a.m. – 10:40 a.m. Discussion of presentation 4
   
10:40 a.m. – 11:10 a.m. Open Forum: Other research ideas
   
11:10 a.m. – 12:00 p.m. Expanded discussion of presentation 1
   
12:00 p.m. – 1:00 p.m. Lunch
   
1:00 p.m. – 1:50 p.m. Expanded discussion of presentation 2
   
1:50 p.m. – 2:40 p.m. Expanded discussion of presentation 3
   
2:40 p.m. – 2:50 p.m. Break
   
2:50 p.m. – 3:40 p.m. Expanded discussion of presentation 4
   
3:40 p.m. – 3:50 p.m. Summary of discussion
Michael Allon
   
3:50 p.m. – 4:00 p.m. Next steps
Robert Star
   
​​

Directions/Travel

Hotel Accommodations

DoubleTree Bethesda
8120 Wisconsin Avenue
Bethesda, MD  20814
Phone:  (301) 652-2000 or (800) 955-7359

Website:  http://www.doubletreebethesda.com/
(More hotel information can be obtained from this website.)

The hotel provides complementary Wi-Fi and a Shuttle Service from the Hotel to the NIH campus for the guests who attend the Vascular Accesses Roundtable on July 18, 2016.

Government Room Rate

A limited block of sleeping rooms for meeting participants has been reserved at the DoubleTree Bethesda Hotel. The rate is the prevailing government rate of $174 per night for single occupancy, plus tax (13%). To reserve a hotel room at the group rate, call reservations at (800) 955-7359 or 652-2000 and use Group Code: VA7. The room block will be in effect at the Government rate only until Friday, July 1, 2016, or until full, whichever comes first. Any room reservations received after this date will be accepted on a space and rate-availability basis.

Reservation Dates

Book arrival on Sunday, July 17, 2016, and departure on Tuesday, July 19, 2016. If you require alternate dates, please send an email to Robert Watson of The Scientific Consulting Group, Inc. (SCG) at rwatson@scgcorp.com. Any alternate date requests will need to be approved through the NIDDK.

Check-in

Please be certain that the hotel provides you with a confirmation number for your reservation. After July 1, 2016, the official room block will be released, and the hotel may charge significantly higher rates and may be sold out. When making a reservation, please provide your room and bedding preferences. The hotel will assign specific room types at check-in, based on availability. Please be advised that requests are not guaranteed. Check-in time is 4:00 p.m., and checkout time is 12:00 p.m.

Cancellations

If you need to cancel your reservation, please do so by 4:00 p.m. on the day prior to arrival, or you will be charged a no-show fee for 1 night on your credit card.

NIH Visitor Information 

Information on visiting the NIH, campus maps, shuttle schedules, driving directions, security, and more can be found on the NIH Visitor Information page. ​​

Minutes

Minutes are currently unavailable.

Attendees

Attendees are currently unavailable.

Abstracts

Submission Deadline

July 5, 2016

Submitting Abstracts

All proposals must be submitted via email to Melissa Frohna, mfrohna@scgcorp.com, with “Hemodialysis Vascular Access Roundtable” in the subject line. Please use one page for each proposal and submit the entirety as one MS Word document.

Abstract Organization

Organize the body of the abstract as follows:

  • Unmet Need/Potential Clinical Impact-how will clinical management be changed/improved?  (3-4 sentence description)
  • Study Design: (e.g., observational cohort study, randomized clinical trial, etc.)
  • Clinical Question (with first suggested topic of unmet need/potential clinical impact)
  • Hypothesis(es)
  • Eligibility/exclusion criteria/population (Target population)
  • Outcome measures (primary and secondary)
  • Duration
  • Is there preliminary evidence to support your proposed study? (several sentences, with several citations)
  • Sample Size consideration (semi-quantitative, small <500, medium 500-1,000 or large >1,000 participants; alternative number of hemodialysis units)
  • If a randomized clinical trial (unit of randomization, individual patients, hemodialysis units, etc.)
  • Unknowns: (what do we need to know before we undertaken the proposed the study?)

Formatting Requirements

Please follow the instructions below to format an abstract. (Note: Submissions will not be edited for spelling or grammar and will be accepted “as is.”)

  • The abstract should be an MS Word document with 1-inch margins, typed single space, using a font no smaller than 10 points (12 cpi). Please use a common font, such as Helvetica, Times New Roman, or Arial.
  • The abstract’s title should be typed in bold and should clearly represent the nature of the proposal. Do not use subheadings (e.g., Methods, Results).
  • List the name and affiliation of the proposer.
  • Do not insert blank lines between the title and the body of the proposal or between paragraphs.
  • Please ensure that your proposal does not exceed one page.
  • Use standard abbreviations (e.g., RBC) and standard symbols for units of measure (e.g., kg, g, mg, mL, L, and %). Place abbreviations and acronyms in parentheses after the full word the first time that the term appears. Use numerals to indicate numbers, except as the first word of a sentence.
  • Simple tables or graphs may be included; however, the proposal may not be longer than one page, including any tables or graphs.

Location

Line
  • National Institutes of Health, Building 35A
  • Room GE620/630
  • MD 20892
Webinar

Contacts

Line

Program Content

Kevin C. Abbott, MD, MPH
Program Officer, KUH, NIDDK
T: 301-594-7714
E: kevin.abbott@nih.gov

Meeting Logistics

Melissa Frohna
The Scientific Consulting Group, Inc.
T: 301-670-4990
E: mfrohna@scgcorp.com